Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -1.67% | 292.23 | 1.4% | $590.52m | |
| AMGN | Amgen, Inc. | 0.07% | 234.01 | 1.3% | $503.19m | |
| GILD | Gilead Sciences, Inc. | 1.04% | 67.78 | 1.0% | $366.31m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.59% | 373.53 | 2.6% | $302.52m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.12% | 220.00 | 1.9% | $273.01m | |
| ILMN | Illumina, Inc. | -1.95% | 320.57 | 3.5% | $231.88m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -3.73% | 68.22 | 11.4% | $207.81m | |
| CLVS | Clovis Oncology, Inc. | -3.14% | 11.72 | 14.7% | $207.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.53% | 109.50 | 2.0% | $195.03m | |
| EXAS | EXACT Sciences Corp. | -0.15% | 85.17 | 24.0% | $163.33m | |
| A | Agilent Technologies, Inc. | 0.60% | 83.43 | 1.6% | $159.09m | |
| GBT | Global Blood Therapeutics, Inc. | 3.29% | 78.45 | 6.0% | $142.09m | |
| BLUE | bluebird bio, Inc. | 1.49% | 86.97 | 14.2% | $139.80m | |
| BOLD | Audentes Therapeutics, Inc. | -0.12% | 59.44 | 1.4% | $134.26m | |
| SGEN | Seattle Genetics, Inc. | -2.32% | 111.34 | 6.1% | $128.54m |
Company Profile
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.